The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBH Macro GBP Regulatory News (BHMG)

Share Price Information for BH Macro GBP (BHMG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 360.00
Bid: 359.50
Ask: 360.00
Change: 0.50 (0.14%)
Spread: 0.50 (0.139%)
Open: 359.00
High: 361.00
Low: 359.00
Prev. Close: 359.50
BHMG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Closing of Tender Offer - Timetable Update

26 Jul 2021 10:01

BH Macro Limited - Closing of Tender Offer - Timetable Update

BH Macro Limited - Closing of Tender Offer - Timetable Update

PR Newswire

London, July 26

THIS ANNOUNCEMENT IS NOT FOR DISTRIBUTION IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH ITS DISTRIBUTION MAY BE UNLAWFUL

BH MACRO LIMITED(a closed-ended investment company incorporated in Guernsey with registration number 46235)LEI: 549300ZOFF0Z2CM87C29

26 July 2021

Closing of Tender Offer – Timetable Update

Further to previous announcements, BH Macro Limited (the “Company”) now expects that the final tender prices in respect of the tender offer for each class of the Company’s shares launched on 2 June 2021 (the “Tender Offer”) at a price equivalent to 97.8% of the net asset value per share for the relevant class as at 30 June 2021 will be announced on or before 2 August 2021.

The Tender Offer consideration despatched to tendering shareholders by 6 August 2021 or as soon as practicable thereafter. 

Enquiries

Richard HorlickChairman

William SimmondsJ.P. Morgan Cazenove020 7742 4000

Edward Berry / Tom BlackwellFTI Consulting07703 330 199 / 07747 113 919

Important notices

J.P. Morgan Securities plc, which conducts its UK investment banking activities as J.P. Morgan Cazenove ("J.P. Morgan Cazenove"), which is authorised by the Prudential Regulation Authority and regulated by the Prudential Regulation Authority and the Financial Conduct Authority in the United Kingdom, is acting exclusively for the Company and no-one else in connection with the Tender Offer and will not be responsible to anyone other than the Company for providing the protections afforded to customers of J.P. Morgan Cazenove or for providing advice in relation to the Tender Offer or any other matter referred to herein.

This announcement does not constitute an offer or solicitation to acquire or sell any securities in the Company. The Tender Offer will not be extended into any jurisdiction where to do so may be unlawful or which may otherwise subject the Company or any other person to any unduly onerous obligation.

This announcement is not for distribution in or into the United States, Canada, Australia or Japan or any other jurisdiction in which its distribution may be unlawful. This announcement is not an offer of securities for sale in the United States or elsewhere. The securities of the Company have not been and will not be registered under the United States Securities Act of 1933, as amended (the "Securities Act"), and may not be offered or sold in the United States unless registered under the Securities Act or pursuant to an exemption from such registration. The Company has not been and will not be registered under the US Investment Company Act of 1940, as amended, and investors are not entitled to the benefits of that Act. There has not been and there will be no public offering of the Company's securities in the United States.

Date   Source Headline
27th Jun 20233:33 pmPRNNet Asset Value(s)
26th Jun 20235:24 pmPRNNet Asset Value(s)
4th May 20237:00 amRNSKepler Trust Intelligence: New Research
28th Apr 20235:00 pmPRNInvestor Statement - March 2023
6th Apr 20233:59 pmRNSResults analysis from Kepler Trust Intelligence
13th Feb 20236:00 pmRNSBH Macro
22nd Sep 20227:00 amRNSResults analysis from Kepler Trust Intelligence
21st Sep 20227:00 amRNSKepler Trust Intelligence: New Research
1st Jun 20225:17 pmPRNConversion of Securities
1st Jun 202211:49 amPRNConversion of Securities
31st May 20224:08 pmPRNNet Asset Value(s)
27th May 20229:24 amPRNNet Asset Value(s)
26th May 20223:15 pmPRNIssue of Equity
24th May 20224:36 pmRNSPrice Monitoring Extension
24th May 20223:57 pmPRNPotential Share Issuance
24th May 20223:51 pmPRNTransparency Report
24th May 20223:22 pmPRNNet Asset Value(s)
23rd May 202212:06 pmPRNHolding(s) in Company
12th Apr 20223:58 pmPRNNet Asset Value(s)
12th Apr 202210:30 amPRNAdditional Disapplication of Pre-emption Rights
11th Apr 202210:12 amRNSResults analysis from Kepler Trust Intelligence
7th Apr 20229:50 amPRNBlock Listing Six Monthly Return
6th Apr 20224:04 pmPRNNet Asset Value(s)
4th Apr 20225:50 pmPRNShare Conversion Request (March 2022)
4th Apr 20223:43 pmPRNHolding(s) in Company
1st Apr 20225:22 pmPRNConversion of Securities
31st Mar 20227:00 amPRNAnnual Report & Audited Financial Statements 2021
30th Mar 20226:31 pmPRNTransparency Report
29th Mar 20224:21 pmPRNNet Asset Value(s)
25th Mar 20222:20 pmPRNNet Asset Value(s)
24th Mar 20229:13 amPRNMonthly Shareholder Report - February 2022
22nd Mar 20222:22 pmPRNNet Asset Value(s)
16th Mar 20225:49 pmPRNIssue of Equity
15th Mar 20224:02 pmPRNAnnouncement of Potential Share Issuance
15th Mar 20222:19 pmPRNNet Asset Value(s)
11th Mar 20223:21 pmPRNHolding(s) in Company
10th Mar 202210:25 amPRNHolding(s) in Company
9th Mar 20223:54 pmPRNShare Conversion Request (Feb 2022)
8th Mar 20223:14 pmPRNNet Asset Value(s)
7th Mar 202212:41 pmPRNConversion of Securities
3rd Mar 20226:26 pmPRNNet Asset Value(s)
2nd Mar 20224:51 pmPRNNet Asset Value(s)
1st Mar 20225:12 pmPRNNet Asset Value(s)
28th Feb 202212:33 pmPRNMonthly Shareholder Report - January 2022
22nd Feb 20222:21 pmPRNNet Asset Value(s)
21st Feb 20222:09 pmPRNTransparency Reporting
15th Feb 20224:24 pmPRNNet Asset Value(s)
15th Feb 20222:30 pmPRNHolding(s) in Company
8th Feb 20225:57 pmPRNNet Asset Value(s)
4th Feb 20223:38 pmPRNShare Conversion Request (Jan 2022)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.